Skip to main content
. 2021 Aug 9;19(3):376–386. doi: 10.1080/2090598X.2021.1959261

Table 2.

Comparison of adverse events between the T-group following long-term treatment with TU and the C-group

Adverse events T-group C-group P
N 312 184  
Deaths, n (%) 25 (7.8) 28 (15.2) 0.035
Deaths due to CVD, n (%)
Myocardial infarction
Stroke
Heart failure
Aortic aneurysm
Lung embolism
11 (44)*
5 (20)
2 (8)
2 (8)
1 (4)
1 (4)
28 (100)
13 (48)
7 (27)
3 (11)
2 (7)
2 (7)
 

*P < 0.001.